首页> 美国卫生研究院文献>Journal of Cancer >miRNA-21 and miRNA-223 expression signature as a predictor for lymph node metastasis distant metastasis and survival in kidney renal clear cell carcinoma
【2h】

miRNA-21 and miRNA-223 expression signature as a predictor for lymph node metastasis distant metastasis and survival in kidney renal clear cell carcinoma

机译:miRNA-21和miRNA-223表达特征可预测肾透明细胞癌淋巴结转移远处转移和生存

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

>Purpose: The aim of this study was to generate a novel miRNA expression signature to effectively assess nodal metastasis, distant metastasis and predict prognosis for patients with kidney renal clear cell carcinoma (KIRC) and explore its potential mechanism of affecting the prognosis.>Method: Using expression profiles downloaded from the Cancer Genome Atlas database, we identified multiple miRNAs with differential expression between KIRC and paired normal tissues. The diagnostic values of the differentially expressed miRNAs for nodal metastasis and distant metastasis were evaluated by Receiver Operating Characteristic (ROC) curve analysis. Then, we evaluated the impact of miRNAs on overall survival (OS) by univariate and multivariate COX regression analyzes. This analysis was ultimately used to construct a miRNA signature that effectively assessed nodal metastasis, distant metastasis and predicted prognosis. The functional enrichment analysis of the miRNAs included in the signatures was used to explore its potential molecular mechanism in KIRC.>Results: Based on our cutoff criteria (P < 0.05 and |log2FC| > 1.0), we identified 104 differentially expressed microRNAs (miRNAs), including 43 that were up-regulated in KIRC tissues and 61 that were down-regulated. We found 12 miRNAs were potentially diagnostic biomarkers of nodal metastasis and distant metastasis by ROC curve analysis. Two miRNAs (miRNA-21 and miRNA-223) were significant miRNAs independently associated with OS based on Cox univariate and multivariate analysis. We generated a signature index based on expression of these two miRNAs, and the two-miRNA signature is promising as a biomarker for diagnosing nodal metastasis, distant metastasis and predicting 5-year survival rate of KIRC with areas under the curve (AUC)=0.738, 0.659 and 0.731, respectively. Patients were stratified into high-risk and low-risk groups, according to median of the signature prognosis indexes. Patients in the high-risk group had significantly shorter survival times than those in the low-risk group (P = 0.000). The functional enrichment analysis suggested that the target genes of two miRNAs may be involved in various pathways related to cancer, p53 signaling pathway, apoptosis, and MAPK signaling pathway.>Conclusion: The two-miRNA signature could assess nodal metastasis, distant metastasis and predict survival of KIRC. As a promising prediction tool, the mechanism of the two miRNAs in KIRC deserves further study.
机译:>目的:本研究的目的是产生新的miRNA表达特征,以有效评估肾透明细胞癌(KIRC)患者的淋巴结转移,远处转移并预测其预后,并探讨其潜在的机制。 >方法:使用从Cancer Genome Atlas数据库下载的表达谱,我们发现了多个在KIRC和配对正常组织之间差异表达的miRNA。通过受体工作特征(ROC)曲线分析评估了差异表达的miRNA对淋巴结转移和远处转移的诊断价值。然后,我们通过单变量和多变量COX回归分析评估了miRNA对整体生存(OS)的影响。该分析最终用于构建有效评估淋巴结转移,远处转移和预测预后的miRNA标记。使用签名中包含的miRNA的功能富集分析来探索其在KIRC中的潜在分子机制。>结果:根据我们的截断标准(P <0.05和| log2FC |> 1.0),我们确定了104种差异表达的microRNA(miRNA),包括在KIRC组织中上调的43个和下调的61个。通过ROC曲线分析,我们发现12个miRNAs可能是淋巴结转移和远处转移的诊断生物标志物。基于Cox单变量和多变量分析,两个miRNA(miRNA-21和miRNA-223)是与OS独立相关的重要miRNA。我们基于这两个miRNA的表达生成了一个签名指数,并且两个miRNA签名有望作为诊断结节转移,远处转移并预测曲线下面积(AUC)= 0.738的KIRC的5年生存率的生物标志物。 ,0.659和0.731。根据签名预后指标的中位数,将患者分为高危和低危组。高风险组的患者生存时间明显短于低风险组(P = 0.000)。功能富集分析表明,两个miRNA的靶基因可能参与了与癌症,p53信号通路,细胞凋亡和MAPK信号通路相关的各种途径。>结论:两个miRNA信号可以评估结节转移,远处转移并预测KIRC的生存。作为有前途的预测工具,KIRC中两个miRNA的机制值得进一步研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号